Home > Healthcare > Medical Devices > Diagnostic Devices > Microbial Identification Market

Microbial Identification Market Size

  • Report ID: GMI9221
  • Published Date: Apr 2024
  • Report Format: PDF

Microbial Identification Market Size

Microbial Identification Market size was valued at around USD 4.2 billion in 2023 and is estimated to grow at 8.8% CAGR from 2024 to 2032. Microbial identification is the process of determining the specific type or species of microorganisms present in a given sample. This involves identifying bacteria, viruses, fungi, parasites, or other microscopic organisms based on their unique characteristics such as morphological features, biochemical properties, genetic composition, or antigenic profiles.

 

The goal of microbial identification is to accurately classify microorganisms to understand their role in various contexts including disease diagnosis, environmental monitoring, food safety, pharmaceutical development, and biotechnology applications. The increasing prevalence of infectious diseases such as bacterial infections, viral infections, parasitic infections, etc. in microbial identification is significant driving factor for the market.
 

For instance, in 2022 World Health Organization (WHO) estimated that 254 million people were living with chronic hepatitis B infection, with 1.2 million new infections. During the year, hepatitis B caused an estimated 1.1 million deaths, due to complications such as cirrhosis and hepatocellular carcinoma (primary liver cancer). Thus, these underscore the critical need for advanced microbial identification solutions to effectively diagnose, treat, and prevent such infections.
 

Furthermore, rising technological advancements, growing awareness and screening programs, and increasing awareness about food safety, are the contributing factors stimulating the growth of the market.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global microbial identification market size was valued at USD 4.2 billion in 2023 and is estimated to grow at 8.8% CAGR from 2024 to 2032, driven by the increasing prevalence of infectious diseases.

Microbial identification industry from the clinical diagnostics segment is likely witness USD 2 billion by 2032, as they accurately identify microbial pathogens causing infections in patients.

The U.S. microbial identification market is anticipated to grow at 8.5% CAGR during 2024-2032, owing to the advances in genomics, proteomics, mass spectrometry, and bioinformatics.

Avantor, Inc., bioMérieux SA, Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter, Inc, Biolog, Inc., Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Qiagen N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Wickham Micro Limited

Microbial Identification Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 13
  • Tables & Figures: 300
  • Countries covered: 23
  • Pages: 230
 Download Free Sample